About Class E basic helix-loop-helix protein 22
Class E basic helix-loop-helix protein 22 (BHLHE22) is a protein
from Homo sapiens identified by UniProt accession
Q8NFJ8, 381 residues long.
MolForge cross-references it against 0 known binders and
77 disease associations.
Target properties
| Protein name | Class E basic helix-loop-helix protein 22 |
| UniProt accession | Q8NFJ8 |
| Gene | BHLHE22 |
| Organism | Homo sapiens |
| Length | 381 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (77)
Diseases linked to this target (Open Targets).
- risk-taking behaviour · score 0.42
- systolic blood pressure · score 0.35
- neurodegenerative disease · score 0.35
- cortical thickness · score 0.33
- schizophrenia · score 0.30
- age at first sexual intercourse measurement · score 0.29
- skin aging measurement · score 0.27
- body height · score 0.25
- smoking initiation · score 0.21
- metabolite measurement · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NFJ8-F1 | alphafold | PREDICTED | 57.92 | — |
Amino-acid sequence (381 residues)
MERGMHLGAA AAGEDDLFLH KSLSASTSKR LEAAFRSTPP GMDLSLAPPP RERPASSSSS PLGCFEPADP EGAGLLLPPP GGGGGGSAGS GGGGGGGVGV PGLLVGSAGV GGDPSLSSLP AGAALCLKYG ESASRGSVAE SSGGEQSPDD DSDGRCELVL RAGVADPRAS PGAGGGGAKA AEGCSNAHLH GGASVPPGGL GGGGGGGSSS GSSGGGGGSG SGSGGSSSSS SSSSKKSKEQ KALRLNINAR ERRRMHDLND ALDELRAVIP YAHSPSVRKL SKIATLLLAK NYILMQAQAL EEMRRLVAYL NQGQAISAAS LPSSAAAAAA AAALHPALGA YEQAAGYPFS AGLPPAASCP EKCALFNSVS SSLCKQCTEK P
Explore Class E basic helix-loop-helix protein 22 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets